Expanding a Long COVID clinic to provide better care for diverse patients
Broadening the scale and impact of a comprehensive Long COVID clinic to serve diverse patient groups with multidisciplinary care and research access
This study is working to make it easier for people, especially those from underserved communities, to get the help they need at a Long COVID clinic, where they can receive personalized care from a team of experts as they recover from COVID-19.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10866266 on NIH RePORTER |
What this research studies
This research aims to enhance the capacity and accessibility of a Long COVID clinic that offers multidisciplinary care to individuals recovering from COVID-19. The project will focus on serving underserved and minority populations by expanding operations at the UCSF OPTIMAL Long COVID Clinic and collaborating with San Francisco General Hospital. Patients will receive coordinated, person-centered care that addresses their unique needs and improves health outcomes. The approach includes evaluating and implementing best practices for equitable care delivery.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals experiencing Long COVID symptoms, particularly those from underserved and minority backgrounds.
Not a fit: Patients who are not experiencing Long COVID symptoms or those who do not have access to the participating clinics may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve health outcomes for patients suffering from Long COVID by providing tailored, comprehensive care.
How similar studies have performed: Other clinics have shown success in providing multidisciplinary care for Long COVID, indicating that this approach has potential for positive outcomes.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Santhosh, Lekshmi — University of California, San Francisco
- Study coordinator: Santhosh, Lekshmi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.